Accéder au contenu
MilliporeSigma

Loss of estrogen-related receptor alpha disrupts ventral-striatal synaptic function in female mice.

Neuroscience (2016-05-08)
Héctor De Jesús-Cortés, Yuan Lu, Rachel M Anderson, Michael Z Khan, Varun Nath, Latisha McDaniel, Michael Lutter, Jason J Radley, Andrew A Pieper, Huxing Cui
RÉSUMÉ

Eating disorders (EDs), including anorexia nervosa, bulimia nervosa and binge-ED, are mental illnesses characterized by high morbidity and mortality. While several studies have identified neural deficits in patients with EDs, the cellular and molecular basis of the underlying dysfunction has remained poorly understood. We previously identified a rare missense mutation in the transcription factor estrogen-related receptor alpha (ESRRA) associated with development of EDs. Because ventral-striatal signaling is related to the reward and motivation circuitry thought to underlie EDs, we performed functional and structural analysis of ventral-striatal synapses in Esrra-null mice. Esrra-null female, but not male, mice exhibit altered miniature excitatory postsynaptic currents on medium spiny neurons (MSNs) in the ventral striatum, including increased frequency, increased amplitude, and decreased paired pulse ratio. These electrophysiological measures are associated with structural and molecular changes in synapses of MSNs in the ventral striatum, including fewer pre-synaptic glutamatergic vesicles and enhanced GluR1 function. Neuronal Esrra is thus required for maintaining normal synaptic function in the ventral striatum, which may offer mechanistic insights into the behavioral deficits observed in Esrra-null mice.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-GluR1 Antibody, clone C3T, rabbit monoclonal, culture supernatant, clone C3T, Upstate®
Sigma-Aldrich
Anticorps anti-phospho-GluR1 (Ser831), clone N453, monoclonal de lapin, culture supernatant, clone N453, Upstate®
Sigma-Aldrich
Anticorps anti-récepteur du glutamate 1 phosphoSer 845, Chemicon®, from rabbit